DoW Duchenne Muscular Dystrophy, Idea Development Award
Funds an early-stage idea in Duchenne muscular dystrophy research, without requiring a clinical trial.
A new idea about treating Duchenne muscular dystrophy rarely arrives with years of supporting data attached. This award funds the idea at exactly that early stage, on the strength of the hypothesis itself.
It funds new, early-stage DMD ideas with the potential to yield impactful data or open new lines of investigation — high-risk, high-reward work rather than incremental confirmation. DoW specifi…
Early-stage, high-risk/high-reward Duchenne muscular dystrophy research ideas, open to Established Investigators, Early-Stage New Investigators and Investigators transitioning into DMD from another field, each reviewed separately. Preliminary DMD-relevant data are required; clinical trials and clinical trial aims are not allowed.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up